Robert L. Rosiello
Valeant Pharmaceuticals International
Executive Vice President and Chief Financial Officer
In 2015, Robert L. Rosiello earned a total compensation of $60.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.
|Ranking||9 out of 13,586|
Robert L. Rosiello's 2015 compensation ranked 9th out of 13,586 executive pay records tracked by us this year.
Rosiello earned more than 99.9% of all executives tracked by us in 2018.
|Ranking||4 out of 1,485|
In the industry group of Drugs, Rosiello's pay ranked 4th out of 1,485 executive pay records tracked by us in 2015.
Rosiello earned more than 99.7% of executives in this group.
|Non-Equity Incentive Plan||$712,184|
Rosiello received $53.1M in stock awards, which accounts for 87.96% of total compensation.
Rosiello also received $6M in bonus, $712.2K in non-equity incentive plan, $546.2K in salary and $13.8K in other compensation.